No at 90.5% reflects the absence of any disease achieving sustained human-to-human transmission capable of global spread through mid-2026. Official monitoring by WHO and CDC shows recent Ebola and hantavirus events remain regionally contained or travel-linked without pandemic-scale growth, while H5N1 avian influenza lacks confirmed efficient person-to-person spread despite ongoing surveillance for genetic changes. Enhanced post-COVID preparedness, including improved diagnostics and early-warning systems, further supports trader consensus. A realistic challenge could arise from rapid viral evolution enabling airborne transmission of a zoonotic pathogen or unexpected escalation of filovirus outbreaks beyond current containment thresholds.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano$744,565 Wol.
$744,565 Wol.
Dec 31, 2026
$744,565 Wol.
$744,565 Wol.
Dec 31, 2026
This market will resolve to "Yes" if the World Health Organization (WHO) declares any disease a pandemic between January 1, 2026 and December 31, 2026 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source will be official announcements from the World Health Organization.No at 90.5% reflects the absence of any disease achieving sustained human-to-human transmission capable of global spread through mid-2026. Official monitoring by WHO and CDC shows recent Ebola and hantavirus events remain regionally contained or travel-linked without pandemic-scale growth, while H5N1 avian influenza lacks confirmed efficient person-to-person spread despite ongoing surveillance for genetic changes. Enhanced post-COVID preparedness, including improved diagnostics and early-warning systems, further supports trader consensus. A realistic challenge could arise from rapid viral evolution enabling airborne transmission of a zoonotic pathogen or unexpected escalation of filovirus outbreaks beyond current containment thresholds.
This market will resolve to "Yes" if the World Health Organization (WHO) declares any disease a pandemic between January 1, 2026 and December 31, 2026 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source will be official announcements from the World Health Organization.
The resolution source will be official announcements from the World Health Organization.
Rynek otwarty: Dec 1, 2025, 4:37 PM ET
Wolumen
$744,565Data zakończenia
Dec 31, 2026Rynek otwarty
Dec 1, 2025, 4:37 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the World Health Organization (WHO) declares any disease a pandemic between January 1, 2026 and December 31, 2026 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source will be official announcements from the World Health Organization.No at 90.5% reflects the absence of any disease achieving sustained human-to-human transmission capable of global spread through mid-2026. Official monitoring by WHO and CDC shows recent Ebola and hantavirus events remain regionally contained or travel-linked without pandemic-scale growth, while H5N1 avian influenza lacks confirmed efficient person-to-person spread despite ongoing surveillance for genetic changes. Enhanced post-COVID preparedness, including improved diagnostics and early-warning systems, further supports trader consensus. A realistic challenge could arise from rapid viral evolution enabling airborne transmission of a zoonotic pathogen or unexpected escalation of filovirus outbreaks beyond current containment thresholds.
This market will resolve to "Yes" if the World Health Organization (WHO) declares any disease a pandemic between January 1, 2026 and December 31, 2026 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source will be official announcements from the World Health Organization.
The resolution source will be official announcements from the World Health Organization.
Wolumen
$744,565Data zakończenia
Dec 31, 2026Rynek otwarty
Dec 1, 2025, 4:37 PM ETResolver
0x65070BE91...No at 90.5% reflects the absence of any disease achieving sustained human-to-human transmission capable of global spread through mid-2026. Official monitoring by WHO and CDC shows recent Ebola and hantavirus events remain regionally contained or travel-linked without pandemic-scale growth, while H5N1 avian influenza lacks confirmed efficient person-to-person spread despite ongoing surveillance for genetic changes. Enhanced post-COVID preparedness, including improved diagnostics and early-warning systems, further supports trader consensus. A realistic challenge could arise from rapid viral evolution enabling airborne transmission of a zoonotic pathogen or unexpected escalation of filovirus outbreaks beyond current containment thresholds.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania